Impact of various red cell concentrate preparation methods on the efficiency of prestorage white cell filtration and on red cells during storage for 42 days

Transfusion

Volumn 37, Issue 11-12, 1997, Pages 1137-1142

  Muller Steinhardt M ^a   Janetzko, K ^a   Kandler, R ^b   Flament, J ^c   Kirchner, H ^a   Kluter H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Baxter Biotech   (United States)

^c Baxter R and D Europe   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; ARTICLE; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; FILTER; FILTRATION; HEMOLYSIS; HLA SYSTEM; LEUKOCYTE; LEUKOCYTE COUNT;

EID: 2642655269     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37111298088042.x     Document Type: Article

References (18)

1. Sniecinski I, O'Donnell MR, Nowicki B, Hill LR. Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 1988;71:1402-7.
2. Andreu G. Role of leukocyte depletion in the prevention of transfusion-induced cytomegalovirus infection. Semin Hematol 1991;28(3 Suppl 5):26-31.
3. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
4. Norfolk DR, Williamson LM. Leucodepletion of blood products by filtration. Blood Rev 1995;9:7-14.
5. Blajchman MA. Cytokines in transfusion medicine (editorial). Transfusion 1993;33:1-3.
6. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794-7.
7. Stack G, Snyder EL. Leukodepletion to prevent transfusion reactions: effects on cytokines and other biologic response modifiers. In: Sweeney J, Heaton A, eds. Clinical benefits of leukodepleted blood products. Austin, TX: R.G. Landes, 1995:61-80.
8. Rider JR, Moore G, Payrat JM, et al. Evaluation of a new, integral, whole blood filter (RS2000) system for prestorage leucodepletion of SAG-M red cells. Br J Haematol 1996;94:184-90.
9. Masse M, Naegelen C, Pellegrini N, et al. Validation of a simple method to count very low white cell concentrations in filtered red cells or platelets. Transfusion 1992;32:565-71.
10. Muylle L, Joos M, Wouters E, et al. Increased tumor necrosis factor α (TNF α), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFa and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-9.
11. Stack G, Baril L, Napychank P, Snyder EL. Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion 1995;35:199-203.
12. Sprogøe-Jakobsen U, Sætre AM, Georgsen J. Preparation of white cell-reduced red cells by filtration: comparison of a bedside filter and two blood bank filter systems. Transfusion 1995;35:421-6.
13. 10 prestorage leucocyte depletion on red cell storage and metabolism. Br J Haematol 1994;87:363-8.
14. Rogers SE, Edmondson D, Goodrick MJ, et al. Prestorage white cell reduction in saline-adenine-glucose-mannitol red cells by use of an integral filter: evaluation of storage values and in vivo recovery. Transfusion 1995;35:727-33.
15. Pietersz RN, Reesink HW, de Korte D, et al. Storage of leukocyte-poor red cell concentrates: filtration in a closed system using a sterile connection device. Vox Sang 1989;57:29-36.
16. Steneker I, Pietersz RN, Reesink HW. Leukocyte filtration mechanisms. Factors influencing the removal of infectious agents from red cell concentrates. Immunol Invest 1995;24:87-93.
17. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
18. Council of Europe. Guide to the preparation, use, and quality assurance of blood components. Strasbourg, France: Council of Europe Press, 1995.